Clinical Trial Awareness Among Racial/Ethnic Minorities in HINTS 2007: Sociodemographic, Attitudinal, and Knowledge Correlates

被引:61
|
作者
Langford, Aisha [1 ]
Resnicow, Ken [1 ]
An, Lawrence [2 ]
机构
[1] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Internal Med, Sch Med, Ann Arbor, MI 48109 USA
关键词
AFRICAN-AMERICANS; PARTICIPATION; RECRUITMENT; POPULATIONS; EDUCATION; BARRIERS;
D O I
10.1080/10810730.2010.525296
中图分类号
G2 [信息与知识传播];
学科分类号
05 ; 0503 ;
摘要
The purpose of this study was (1) to examine the association of race/ethnicity on clinical trial awareness, controlling for several sociodemographic, attitudinal, and knowledge variables, and (2) to inform future communication campaigns to increase clinical trial awareness and participation. Secondary analysis was conducted among 6,754 Hispanic, Black, and White adult respondents to the National Cancer Institute's 2007 Health Information National Trends Survey (HINTS). The dependent variable was awareness of clinical trials. Logistic regression was used to examine possible correlates of clinical trial awareness including sociodemographics, trust of sources of health information, beliefs about safety of health information, family/personal history of cancer, health seeking information, and awareness of three health agencies. Compared with Whites, Blacks and Hispanics were significantly less likely to have heard of a clinical trial. Other significant correlates of clinical trial awareness included education, income, belief that health information is safely guarded, family history of cancer, awareness of the Centers for Disease control, trust of health information from the Internet and charitable organizations, and distrust of health information from religious institutions. Blacks and Hispanics are significantly less aware of clinical trials. Campaigns that exploit unique beliefs and delivery channels for racial/ethnic subgroups should be considered.
引用
收藏
页码:92 / 101
页数:10
相关论文
共 42 条
  • [41] Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer A Post Hoc Analysis of the TAILORx Randomized Clinical Trial
    Kantor, Olga
    King, Tari A.
    Freedman, Rachel A.
    Mayer, Erica L.
    Chavez-MacGregor, Mariana
    Korde, Larissa A.
    Sparano, Joseph A.
    Mittendorf, Elizabeth A.
    JAMA SURGERY, 2023, 158 (06) : 583 - 591
  • [42] Racial and Ethnic Differences in Clinical Outcomes among North American Patients with Hormone Receptor Positive, HER2-negative, Early Breast Cancer in the PALLAS Trial (AFT-05)
    Kantor, Olga
    Fayanju, Oluwadamilola
    Dueck, Amylou
    Gnant, Michael
    Burstein, Harold
    Goetz, Matthew
    Isaacs, Claudine
    Shepherd, Lois
    Hahn, Olwen
    Anderson, Daniel
    Miller, Kathy
    Rugo, Hope
    Traina, Tiffany
    Dayao, Zoneddy
    Clifton, Katherine
    Winer, Eric
    Wolff, Antonio
    Wolmark, Norman
    Lu, Dongrui
    O'Brien, Patrick
    Scovil, Sara
    DeMichele, Angela
    Mayer, Erica
    CANCER RESEARCH, 2024, 84 (09)